BDBM50603811 CHEMBL5171560
SMILES [#6]-[#6]-n1c2nc(-[#6])ccc2c2-[#8][C@@]([#6])([#6]-[#6]-[#8])[#6]-[#6@@H](\[#6]=[#6](\[#6])-[#6])-c2c1=O
InChI Key InChIKey=ARZLBTBCEXMIAN-UHFFFAOYSA-N
Data 11 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 11 hits for monomerid = 50603811
TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Human)
National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 1.76E+3nMAssay Description:Inhibition of PDE10A2 (449 to 770 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for...More data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A(Human)
National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 2.13E+3nMAssay Description:Inhibition of PDE7A1 (130 to 482 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for ...More data for this Ligand-Target Pair
TargetcGMP-specific 3',5'-cyclic phosphodiesterase(Human)
National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 4.25E+3nMAssay Description:Inhibition of PDE5A1 (535 to 860 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for ...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 3.10E+3nMAssay Description:Inhibition of PDE4D2 (86 to 413 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 3.20nMAssay Description:Inhibition of PDE4B2 (152 to 487 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for ...More data for this Ligand-Target Pair
TargetDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B(Human)
National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of PDE1B (10 to 487 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 15...More data for this Ligand-Target Pair
TargetcGMP-dependent 3',5'-cyclic phosphodiesterase(Human)
National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 1.51E+3nMAssay Description:Inhibition of PDE2A (580 to 919 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for 1...More data for this Ligand-Target Pair
TargetcGMP-inhibited 3',5'-cyclic phosphodiesterase 3A(Human)
National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of PDE3A (679 to 1087 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for ...More data for this Ligand-Target Pair
TargetHigh affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A(Human)
National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 820nMAssay Description:Inhibition of PDE8A1 (480 to 820 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for ...More data for this Ligand-Target Pair
TargetHigh affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A(Human)
National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of PDE9A2 (181 to 506 residues) (unknown origin) expressed in Escherichia coli BL21 using [3H-GMP] or [3H-AMP] as substrate incubated for ...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Human)
National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation
Curated by ChEMBL
National-Local Joint Engineering Laboratory of Druggability and New Drugs Evaluation
Curated by ChEMBL
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of hERG by Q patch automated patch-clamp methodMore data for this Ligand-Target Pair